Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 18, 2020LeukemiaOpen Access

Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMarlijn HoeksRadboud University NijmegenTBTimothy BagguleyUniversity of YorkCMCorine van MarrewijkRadboud University Nijmegen

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hoeks et al. (2020) studied this question.

synapsesocial.com/papers/6a9ed2f99e834d122ee99fcbhttps://doi.org/10.1038/s41375-020-01022-2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Plasma Levels of Aminothiols, Nitrite, Nitrate, and Malondialdehyde in Myelodysplastic Syndromes in the Context of Clinical Outcomes and as a Consequence of Iron Overload2014 · 25 citations
  2. 2Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making2005 · 865 citations
  3. 3Labile plasma iron levels predict survival in patients with lower-risk myelodysplastic syndromes2017 · 48 citations
  4. 4Increased parameters of oxidative stress and its relation to transfusion iron overload in patients with myelodysplastic syndromes2013 · 21 citations